Major Events - Longi Technology (09611) plans to globally offer 52.2591 million H-shares from January 14 to January 19 [1] - CK Life Sciences (00013) announced the results of the SACHI III study published in The Lancet [1] - Dongyang Sunshine Pharmaceutical (06887) launched an AI-driven R&D platform targeting the PROTAC mechanism, continuing to deepen its AI strategic layout [1] - Dongyao Pharmaceutical-B (01875) received a cash offer from WuXi AppTec (02268) at a premium of approximately 99%, with resumption of trading on January 15 [1] - Valiant Pharmaceuticals-B (09887) received Fast Track designation from the US FDA for its bispecific antibody, Opalizumab (LBL-024) [1] - Xunqi (03317) entered into a strategic cooperation framework agreement with Jinyong Investment to support digital transformation in investment research, trading, and risk management [1] Operating Performance - CITIC Securities (06030) reported a net profit attributable to shareholders of 30.051 billion yuan for 2025, an increase of 38.46% year-on-year [1] - CITIC Bank (00998) reported a net profit attributable to shareholders of 70.618 billion yuan for 2025, a year-on-year increase of 2.98% [1] - China General Nuclear Power New Energy (01811) completed a cumulative power generation of 19,000 GWh in 2025, a decrease of 0.8% year-on-year [1] - Yuexiu Property (00123) reported a cumulative contract sales amount of approximately 106.21 billion yuan for 2025 [1] - WuXi AppTec (02268) issued a profit warning, expecting a net profit growth of over 38% year-on-year for 2025 [1] - Jinyu Group (02009) issued a profit warning, anticipating a net loss attributable to shareholders of 900 million to 1.2 billion yuan for 2025 [1] - Saijing Technology (00580) issued a profit alert, expecting a net profit increase of approximately 30.0% for 2025 [1] - Beijing Beichen Industrial Co., Ltd. (00588) issued a profit warning, expecting a net loss attributable to shareholders of 2.696 billion to 3.38 billion yuan for 2025 [1]

Company News - CITIC Securities (06030.HK) reported a revenue of RMB 74.83 billion for the fiscal year 2025, representing a year-on-year increase of 28.75%, and a net profit of RMB 30.05 billion, up 38.46% year-on-year [2] - CITIC Bank (00998.HK) announced a total revenue of RMB 212.48 billion for 2025, a slight decrease of 0.55% year-on-year, while net profit increased by 2.98% to RMB 70.62 billion [2] - Beijing North Star Industrial (00588.HK) expects to continue reporting losses for the fiscal year ending December 31, 2025 [3] - Yuexiu Property (00123.HK) reported a cumulative contract sales amount of approximately RMB 106.21 billion for 2025, a decline of about 7.3% year-on-year, achieving 88.1% of its sales target [3] - Jiao Ge Peng You Holdings (01450.HK) achieved a total GMV of approximately RMB 6.49 billion in Q4 2025, a year-on-year increase of about 4.34%, with a cumulative GMV of RMB 16.02 billion for the year, up 6.23% [3] - Sai Jing Technology (00580.HK) anticipates a revenue of approximately RMB 2.25 billion for 2025, reflecting a year-on-year increase of about 40% due to increased revenue from flexible transmission business [3] - China General Nuclear Power New Energy (01811.HK) reported a cumulative power generation of 19,000 GWh for 2025, a decrease of 0.8% year-on-year, with variations in different energy sources [3] - Morning News Technology (02000.HK) reported an unaudited revenue of HKD 397 million for 2025, a decrease of 7.4% year-on-year [3] Financing and Buyback Activities - Chow Tai Fook Enterprises (00659.HK) applied for the registration of debt financing instruments totaling no more than RMB 5 billion [7] - Tencent Holdings (00700.HK) repurchased 1.006 million shares at a cost of approximately HKD 636 million, with repurchase prices ranging from HKD 626 to HKD 638 [7] - Xiaomi Group-W (01810.HK) repurchased 4 million shares for approximately HKD 151 million, with repurchase prices between HKD 37.61 and HKD 42.50 [7] Research and Development - Hutchison China MediTech (00013.HK) announced the publication of SACHI III study results in The Lancet [4] - Laka Pharmaceuticals-B (02105.HK) had its clinical trial application for the new drug LAE118 accepted by the U.S. FDA [5] Other News - Yuanxu Technology (08637.HK) announced a short suspension of trading starting January 14, pending the release of insider information [6] - Haidilao (06862.HK) redeemed USD 600 million of its 2.150% notes due in 2026 [2]

Core Viewpoint - China General Nuclear Power Corporation (CGN) announced that by December 2025, the group is expected to achieve a total power generation of 1,503.8 GWh, representing a year-on-year increase of 2.6% compared to 2024 [1] Group Summary - The total power generation for the year ending December 31, 2025, is projected to be 19,003.6 GWh, which is a decrease of 0.8% compared to 2024 [1] - The breakdown of power generation changes includes: - Chinese wind power projects increased by 11.4% [1] - Chinese solar power projects increased by 42.0% [1] - Chinese hydropower projects decreased by 37.8% [1] - Korean projects decreased by 17.9% [1] - For the year ending December 31, 2025, the changes in power generation are as follows: - Chinese wind power projects decreased by 0.4% [1] - Chinese solar power projects increased by 31.3% [1] - Chinese gas projects increased by 9.4% [1] - Chinese hydropower projects decreased by 12.3% [1] - Korean projects decreased by 8.3% [1]

Core Viewpoint - China General Nuclear Power Corporation (CGN) New Energy announced that it expects to achieve a total power generation of 1503.8 GWh by December 2025, representing a 2.6% increase compared to 2024 [1] Group 1: Power Generation Performance - For the year ending December 31, 2025, the company completed a total power generation of 19,000 GWh, which is a 0.8% decrease compared to 2024 [1] - The breakdown of power generation shows that wind power projects in China decreased by 0.4%, while solar power projects increased by 31.3% [1] - Gas power projects in China increased by 9.4%, while hydropower projects decreased by 12.3%, and projects in South Korea decreased by 8.3% [1] Group 2: Project-Specific Changes - By December 2025, the company anticipates an 11.4% increase in wind power projects and a 42.0% increase in solar power projects in China [1] - Conversely, hydropower projects in China are expected to decrease by 37.8%, and projects in South Korea are projected to decrease by 17.9% [1]

Core Viewpoint - China General Nuclear Power Corporation (CGN) announced an expected increase in power generation for 2025, with a total of 1503.8 GWh, representing a 2.6% increase compared to 2024 [1] Group 1: Power Generation Forecast - The company anticipates a 2.6% year-on-year increase in power generation for 2025, reaching 1503.8 GWh [1] - The breakdown of projected power generation shows an 11.4% increase in China's wind power projects and a 42.0% increase in China's solar power projects [1] - Conversely, there is a projected decrease of 37.8% in China's hydropower projects and a 17.9% decrease in projects in South Korea [1] Group 2: 2024 Performance Review - For the twelve months ending December 31, 2025, the company reported a cumulative power generation of 19,000 GWh, which is a 0.8% decrease compared to 2024 [1] - The performance of various segments includes a 0.4% decrease in China's wind power projects, a 31.3% increase in China's solar power projects, and a 9.4% increase in China's gas projects [1] - Additionally, there were decreases of 12.3% in China's hydropower projects and 8.3% in South Korean projects [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告內容概不負責，對 其準確性或完整性亦不發表任何聲明，並明確表示概不會就本公告全部或任何部分 內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 2025年12月發電量 本公告乃由中國廣核新能源控股有限公司（「本公司」）發出的自願性公告。 本公司董事會（「董事會」）宣佈根據本公司初步統計，2025年12月本公司及其附屬公 司（「本集團」）按合併報表口徑完成發電量1,503.8吉瓦時，較2024年同比增加2.6%。 其中，中國風電項目增加11.4%，中國太陽能項目增加42.0%，中國水電項目減少 37.8%及韓國項目減少17.9%。截至2025年12月31日止十二個月，本集團今年累計完 成發電量19,003.6吉瓦時，比2024年同比減少0.8%。其中，中國風電項目減少0.4%， 中國太陽能項目增加31.3%，中國燃氣項目增加9.4%，中國水電項目減少12.3%及韓 國項目減少8.3%。 – 1 – 本集團2025年12月及2024年同期發電量詳情如下： CGN NEW ENERGY HOLDINGS CO., LTD. 中國廣核新能源控股有限公司 （ ...

Core Viewpoint - The A-share market saw a significant rise in power stocks on January 13, with notable gains from several companies, indicating a positive trend in the sector [1]. Group 1: Stock Performance - Yunnan Energy Holdings (豫能控股) experienced a surge of 9.98%, with a total market capitalization of 10.1 billion and a year-to-date increase of 27.12% [2]. - Jiaze New Energy (嘉泽新能) rose by 6.21%, reaching a market value of 14.9 billion and a year-to-date increase of 15.54% [2]. - Jilin Electric Power (吉电股份) saw a gain of 5.75%, with a market cap of 22.7 billion and a year-to-date increase of 10.82% [2]. - Xichang Electric Power (西昌电力) increased by 4.62%, with a market capitalization of 5.206 billion and a year-to-date increase of 9.26% [2]. - Leshan Electric Power (乐山电力) rose by 4.24%, with a total market value of 6.402 billion and a year-to-date increase of 13.54% [2]. - Beijing Energy (京能电力) increased by 3.17%, with a market cap of 37.1 billion and a year-to-date increase of 8.63% [2]. - Huaitian Thermal Power (惠天热电) saw a rise of 3.06%, with a market capitalization of 1.977 billion and a year-to-date increase of 7.85% [2]. - Datang Power (大唐发电) increased by 3.04%, with a market value of 6.92 billion and a year-to-date increase of 7.24% [2].

Group 1 - The core point of the article is that China General Nuclear Power Group (CGN) has obtained a patent for a wind turbine pitch control method, system, and storage medium, with the patent number CN116717425B, applied for on July 2023 [1] Group 2 - CGN (Beijing) New Energy Technology Co., Ltd. was established in 2014 and is located in Beijing, primarily engaged in technology promotion and application services [1] - The company has a registered capital of 198 million RMB [1] - According to data analysis, CGN (Beijing) has invested in one company, participated in 1,308 bidding projects, holds 224 patents, and has 10 administrative licenses [1]

致：香港交易及結算所有限公司 公司名稱: 中國廣核新能源控股有限公司 (於百慕達註冊成立的有限公司） FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 呈交日期: 2026年1月6日 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01811 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 250,000,000,000 | HKD | | 0.0001 | HKD | | 25,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | 0 | | 本月底結存 | | | 250,000,000,000 | HKD | | 0.0001 | HKD | ...

国家知识产权局信息显示，中广核（北京）新能源科技有限公司取得一项名为"一种变桨扭矩解耦控制 方法和风力发电系统"的专利，授权公告号CN116696667B，申请日期为2023年7月。 天眼查资料显示，中广核（北京）新能源科技有限公司，成立于2014年，位于北京市，是一家以从事科 技推广和应用服务业为主的企业。企业注册资本19800万人民币。通过天眼查大数据分析，中广核（北 京）新能源科技有限公司共对外投资了1家企业，参与招投标项目1307次，财产线索方面有商标信息1 条，专利信息224条，此外企业还拥有行政许可10个。 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 本文源自：市场资讯 作者：情报员 ...